Clinical Trials Directory

Trials / Completed

CompletedNCT06240442

Bodyweight Interval Exercise in the Fed Versus Fasted State

Bodyweight Interval Exercise in the Fed Versus Fasted State on Postprandial Glycemia, Appetite Perceptions and Fat Oxidation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
University of Toronto · Academic / Other
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to investigate the effects of a single session of at-home bodyweight interval exercise, performed in the fasted or fed state, on postprandial glycemic management, post-exercise fat oxidation, and overall perceptions of appetite in recreationally active females. This is a remote/online study and does not involve any visits to the laboratory.

Detailed description

Following the acquisition of informed consent via videoconferencing, eligibility to participate in the study will be determined using questionnaires. If inclusion criteria is met, participants will undergo virtual exercise familiarization by following a pre-recorded instructional video. Eligible participants will be assigned, in a random order, to two metabolic trials at least 3 days apart in the follicular phase of the same menstrual cycle. These visits will be online with an investigator on videoconferencing. The two trials involve: 1) Exercise followed by breakfast; and 2) Breakfast followed by exercise. Various outcomes will be measured throughout the metabolic trials including: blood sugar, fat oxidation and appetite. All research tools needed to acquire these methods will be delivered to participants' place of residence.

Conditions

Interventions

TypeNameDescription
OTHERFasted exerciseBodyweight interval exercise performed 5 minutes before the start of a mixed-macronutrient breakfast meal
OTHERFed exerciseBodyweight interval exercise performed 10 minutes after the start of consuming a mixed-macronutrient breakfast meal

Timeline

Start date
2021-05-14
Primary completion
2021-08-30
Completion
2021-08-30
First posted
2024-02-05
Last updated
2024-02-05

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT06240442. Inclusion in this directory is not an endorsement.